Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 11/20 | 0.43 |
| ▸ | CA2 | P00918 | 10/20 | 0.43 |
| ▸ | CA12 | O43570 | 6/20 | 0.43 |
| ▸ | CA9 | Q16790 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.40 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28056834 | 0.88 | CA1 (0.49) | CA1CA2CA12CA9CA7 | |
| SCHEMBL27802297 | 0.85 | MAPT (0.50) | MEP1BMAPTCA1CA2CA12 | |
| SCHEMBL3929114 | 0.85 | EGFR (0.53) | MEP1BCA1CA2CA12CA9 | |
| SCHEMBL3368185 | 0.79 | CA12 (0.57) | CA1CA2CA12CA9TSHR | |
| SCHEMBL669133 | 0.79 | PTPN11 (0.49) | MAPTCA1CA2EPHX2 | |
| SCHEMBL19331732 | 0.78 | MAPT (0.51) | MAPTTSHREPHX2 | |
| SCHEMBL13690596 | 0.77 | MAPT (0.48) | MAPTCA1CA2CA12CA9 | |
| SCHEMBL3711894 | 0.76 | CA1 (0.50) | MAPTCA1CA2CA12CA9 | |
| SCHEMBL7669283 | 0.76 | MEP1B (0.58) | MEP1BCA1CA2CA12CA9 | |
| SCHEMBL27165702 | 0.76 | MAPT (0.43) | MAPTCA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037311-B2 | Pre-assembled, protected, chemically stable, chemoselective linkers | Cowper Sciences Inc. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20200407712-A1 | ARRAY-BASED CYCLIC PEPTIDE LIBRARIES | Cowper Sciences Inc. | 2020-12-31 | — | — | US | disclosed |
| EP-3749676-A1 | ARRAY-BASED CYCLIC PEPTIDE LIBRARIES | Healthtell Inc. (US) | 2020-12-16 | — | — | EP | disclosed |
| WO-2019157362-A1 | ARRAY-BASED CYCLIC PEPTIDE LIBRARIES | HEALTHTELL INC. (US) | 2019-08-15 | — | — | WO | disclosed |
| WO-2018089554-A1 | PRE-ASSEMBLED, PROTECTED, CHEMICALLY STABLE, CHEMOSELECTIVE LINKERS | HEALTHTELL INC. (US) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037311-B2 | Pre-assembled, protected, chemically stable, chemoselective linkers | SCLY, ZYX, H1-10 | MEP1B 2457/4885MAPT 3800/4885CA1 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.